Interstitial Lung Diseases in Developing Countries

by Pilar Rivera-Ortega, Maria Molina-Molina
Published 2019-01-01

Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience

by Pilar Rivera-Ortega, Conal Hayton, John Blaikley, Colm Leonard, Nazia Chaudhuri
Published 2018-09-01

The characterisation of interstitial lung disease multidisciplinary team meetings: a global study

by Luca Richeldi, Naomi Launders, Fernando Martinez, Simon L.F. Walsh, Jeffrey Myers, Bonnie Wang, Mark Jones, Alison Chisholm, Kevin R. Flaherty, REG IPF/ILD Working Group collaborators:, Aileen David-Wang, Antonio Morais, Arata Azuma, Bruno Crestani, Carlo Vancheri, Carole Youakim, Charlene D. Fell, Christopher J. Ryerson, Demosthenes Bouros, Elisabeth Bendstrup, Ferran Morell, Francesco Bonella, Ganesh Raghu, George Christoff, Giovanni Ferrara, Ian Glaspole, Ivan Rosas, Jürgen Behr, Kaissa DeBoer, Katerina M. Antoniou, Keertan Dheda, Kevin Brown, Lurdes Planas-Cerezales, Magnus Sköld, Manuela Funke, Maria Molina-Molina, Mariano Mazzei, Martin Kolb, Moises Selman, Paola Rottoli, Paolo Spagnolo, Pilar Rivera-Ortega, Sergey Avdeev, Silvia Quandrelli, Tamera J. Corte, Toby M. Maher, Vincent Cottin, Wim Wuyts, Zuo Jun Xu
Published 2019-04-01